SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - 24.09.2019

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : Securities and Exchange Board of India Aurobindo Pharma Ltd.SEBI

Share :